Page last updated: 2024-08-21

sapropterin and Attention Deficit Disorder with Hyperactivity

sapropterin has been researched along with Attention Deficit Disorder with Hyperactivity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burton, B; Feigenbaum, A; Gillis, J; Grant, M; Hendren, R; Lang, W; Merilainen, M; Phillips, J; Prasad, S; Sanchez-Valle, A; Singh, R; Siriwardena, K; Stahl, S; Waisbren, S; Yu, S; Zhang, C1

Trials

1 trial(s) available for sapropterin and Attention Deficit Disorder with Hyperactivity

ArticleYear
A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria.
    Molecular genetics and metabolism, 2015, Volume: 114, Issue:3

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Biopterins; Child; Dose-Response Relationship, Drug; Double-Blind Method; Executive Function; Female; Humans; Male; Phenylalanine; Phenylketonurias; Young Adult

2015